GlassScriptPhysician profile
Donna M Robinson
NPI 1316365554
$460.43
in general payments reported to CMS, 2019-2025
11 companies · $73.68 in 2025
The $73.68 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.99 · 2022: $170 · 2023: $163 · 2024: $36.80 · 2025: $73.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $144.77 | 2022-2023 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $63.32 | 2022 | |
| Sanofi Pasteur INC. | $49.46 | 2021-2023 | |
| Novo Nordisk INC | $44.43 | 2025 | Ozempic, Rybelsus |
| Corium, LLC | $37.87 | 2022-2023 | Azstarys |
| Exact Sciences Corporation | $29.25 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $22.26 | 2023 | |
| Abbvie INC. | $18.87 | 2024 | |
| Glaxosmithkline, LLC. | $17.93 | 2024 | Pediarix, Bexsero |
| Merck Sharp & Dohme LLC | $17.50 | 2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Alexion Pharmaceuticals, INC. | $14.77 | 2023 | Strensiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.